FDA Approvals - Oculus Innovative Sciences Microcyn(R) Technology Presented in Poster at European
Oculus Innovative Sciences Microcyn(R) Technology Presented in Poster at European Wound Management Association ... (RedNova)
Oculus Innovative Sciences, Inc. (NASDAQ:OCLS) today reported that its Microcyn Technology was the subject of a poster presentation at the European Wound Management Association (EWMA) conference that was held in Glasgow, Scotland this past week.
Abraxis BioScience Receives FDA Approvals for Clindamycin Injection, USP (Business Wire via Yahoo! Finance)
LOS ANGELES----Abraxis BioScience, Inc. , an integrated, global biopharmaceutical company, today announced that it has received two approvals from the U.S. Food and Drug Administration for its Abbreviated New Drug Applications for Clindamycin Injection, 300mg, 600mg, 900mg and 9g, USP, the generic equivalent of Pfizer's Cleocin Phosphate Injection.
Bio-Matrix Scientific Enters into Contract with Validation Systems to Finalize FDA cGMP Quality Systems for First Adult ... (Business Wire via Yahoo! Finance)
SAN DIEGO----Bio-Matrix Scientific Group Inc. , a biotechnology company focused on stem cell cryogenics and disposable stem cell/tissue transfer instruments, announced today it has entered into a contract with Validation Systems, Inc. to complete and finalize its FDA Good Manufacturing Practices Quality Systems documentation.